Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal Plus: Insulin Glulisine Added to Insulin Glargine and OADs in Type 2 Diabetes
NCT00360698Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2006
- Primary completion
- Aug 2008
- Modality
- Peptides
- Countries
- 3
01
Overview
A Phase 4 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2006; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00360698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360698.